AtaiBeckley (XTER:B72) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:B72 AtaiBeckley Inc XTER:B72
55 GF Score
Price €6.10
GF Value €8.78
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AtaiBeckley Net Loan?

Net Loan only applies to banks and insurance companies.

XTER:B72
55GF Score
AtaiBeckley Inc XTER:B72
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtaiBeckley (XTER:B72) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of €6.10 is trading 30.5% below its estimated GF Value™ of €8.78. GuruFocus considers AtaiBeckley to be Possible Value Trap.

Key valuation signals for XTER:B72:

  • Net Loan:
  • GF Value™: €8.78 vs. price of €6.10 (30.5% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the XTER:B72 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtaiBeckley Business Description

Other Exchanges ATAI:USA
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
55GF Score

Get the complete analysis for XTER:B72

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price
€8.78
GF Value